ISRG vs XOM: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Intuitive Surgical, Inc. Β· Healthcare
$399.52
+22.4% upside to fair value
Med Conviction Grade B High Quality
VS
Exxon Mobil Corporation Β· Energy
$163.18
+10.3% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+22.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG XOM
Current Price $399.52 $163.18
Fair Value Estimate $488.97 $179.98
Upside to Fair Value +22.4% +10.3%
Market Cap $141.1B $676.3B
Forward P/E β€” β€”
EV / EBITDA 30.7x 9.9x
Price / Sales 12.8x 1.9x
Price / FCF 44.0x 22.3x
Revenue Growth YoY +18.5% +44.1%
Gross Margin 66.7% 25.1%
Operating Margin 31.3% 10.7%
Return on Equity 17.8% 12.7%
Dividend Yield 0% 2.52%
FCF Yield 2.28% 4.49%
Analyst Consensus Strong Buy Hold
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
XOM β€” Exxon Mobil Corporation
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
Metric ISRG XOM
Zone Low $366.73 $134.98
Zone High $415.62 $152.98
In Buy Zone? Yes No
← ISRG Research    XOM Research β†’    All Research